Tomorrow, January 22, 2021, LifeSciences BC will host the 2^nd Annual Career Connect Day, presented by BioTalent Canada, bringing together Life Science leaders, employers and those interested in pursuing a career in this sector. The day will showcase career opportunities by profiling leading Life Science organizations, associated careers and connections in the sector. 

The conference opens with a fireside chat with The Honourable Ravi Kahlon, Minister of Jobs, Economic Recovery and Innovation and myself. Throughout the day there are sessions planned with Life Sciences leaders sharing their career stories, perspectives and advice while providing guidance on the many career opportunities available throughout B.C. and beyond. With over 600 people registered, 26 company exhibitor booths, it is shaping up to be a great conference. We hope to see you there! For the agenda and registration, please click here.

Please be reminded that we have a very active and current Job Board on our LSBC website. It is updated daily with new opportunities which you can find and apply for here. https://

lifesciencesbc.ca/jobs/

To support the marketing efforts for our 2^nd Annual Career Connect Day, presented by BioTalent Canada, I have been busy fielding numerous media interviews to support awareness of the event. A list of media interviews include: CIVL Radio (University of the Fraser Valley), News 1130 Radio (CKWX), CBC Radio, The Canadian Press, Business in Vancouver, Conversations that Matter (Vancouver Sun - video podcast) with a few more in the coming days. We will post them on our website once they are available for dissemination.

LSBC recently collaborated on an Op-Ed piece with the British Columbia Business Council and Innovative Medicines Canada, that speaks to our sector’s strengths and contribution to B.C.’s economy and now, our economic recovery. We look forward to posting the op-ed once it has been published in the Vancouver Sun.

Also very newsworthy in the last few days, is the exciting announcement from adMare BioInnovations of the launch of Abdera Therapeutics Inc., their third new well-funded spin-off company this fiscal. With AbCellera as a founding partner, Abdera is a precision oncology company developing novel next-generation targeted alpha therapies (TATs) for patients with relapsed, refractory and metastatic cancers. Big congratulations to all who have played a role in this exciting milestone and to the founding CEO, Dr. Lana Janes and Chief Scientific Officer, Dr. Michael Abrams.  You can read the full news release here.

Hope to see everyone Friday, at Career Connect Day! 

VANCOUVER, BC, Jan. 18, 2021 /CNW/ – ImmunoFlex™, a life sciences company developing clinically validated, pharmaceutical grade natural health products based on advancements in genomics research, today announced the approval of FLEX 10™ by Health Canada. READ MORE

January 18, 2021 – Innovative Solutions Canada has posted an Open Call today for innovative prototypes, which includes a Health stream under the standard component. The Testing Stream aims to procure, test and evaluate innovative late stage pre-commercial prototypes. READ MORE

Vancouver, BC – January 19, 2021 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), today announced that executives of the Company will speak at the 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe (“CDP Europe”). READ MORE

January 21, 2021 – The 2020 Innovation to Commercialization and Health Professional-Investigator awardees are advancing health research towards practical applications, improving patient care, and developing made-in-BC technologies. READ MORE

January 21, 2021 – You are invited to an update webinar on the amendments to the PMPRB Guidelines on Friday, January 29, from 12:00 noon to 1:00 p.m. (EST). READ MORE

Hart Jackson’s colleagues at Sinai Health in Toronto have affectionately nicknamed him ‘the human pincushion.’ For months now, Jackson has been routinely pricking his finger to provide blood samples, in hopes of helping to answer a central question in the fight against COVID-19: How long does immunity last? READ MORE

Pfizer Inc. and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the U.S. drugmaker. READ MORE

NEW YORK - Lani Muller doesn’t have to visit a doctor’s office to help test an experimental COVID-19 vaccine — she just climbs into a bloodmobile-like van that parks on a busy street near her New York City neighbourhood. READ MORE

What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here

The Student Work Placement Program is now accepting applications for healthcare placements. Canada’s healthcare industry has a growing need to produce job-ready healthcare workers. There are 1,500 open spots available in 2020-21. WEBSITE

As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? CONTACT: Sue Callaghan - talent@lifesciencesbc.ca